Concomitant monitoring of WT1 and FLT3‐ITD expression in FLT3‐ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?. Issue 5 (22nd March 2017) - De Marchi, Federico; Candoni, Anna; Zannier, Maria Elena; Haley, Lisa; Lau, Bonnie Wing Yin; Fanin, Renato